Evidence-based Treatment Options in Cannabis Dependency

被引:15
|
作者
Walther, Lisa [1 ]
Gantner, Andreas [2 ]
Heinz, Andreas [1 ,3 ]
Majic, Tomislav [3 ]
机构
[1] Charite, Dept Psychiat & Psychotherapy, Campus Mitte, Berlin, Germany
[2] Therapieladen eV, Berlin, Germany
[3] Charite, St Hedwig Hosp, Dept Psychiat & Psychotherapy, Charite Campus Mitte, Berlin, Germany
来源
DEUTSCHES ARZTEBLATT INTERNATIONAL | 2016年 / 113卷 / 39期
关键词
RANDOMIZED CONTROLLED-TRIAL; MULTIDIMENSIONAL FAMILY-THERAPY; COGNITIVE-BEHAVIORAL THERAPY; PLACEBO-CONTROLLED TRIAL; STUDENT MARIJUANA USE; DOUBLE-BLIND; USE DISORDERS; TREATMENT PROGRAM; MOTIVATIONAL ENHANCEMENT; BRIEF INTERVENTION;
D O I
10.3238/arztebl.2016.0653
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Now that the consumption of natural and synthetic cannabinoids is becoming more widespread, the specific treatment of cannabis-related disturbances is an increasingly important matter. There are many therapeutic options, and it is not always clear which ones are evidence-based and appropriate for use in a given clinical situation. Methods: This review is based on reports of pertinent randomized and controlled trials (RCTs) that were retrieved by a selective search in the PubMed and Cochrane databases. Results: Cognitive behavior therapy (CBT) combined with other techniques has been found to have a moderate to large effect (Cohen's d = 0.53-0.9) on the amount of cannabis consumed as well as on the level of psychosocial functioning or the dependence syndrome. Systemic multidimensional family therapy (MDFT) has been found beneficial for younger adolescents who consume large amounts of cannabis and have psychiatric comorbidities. Short-term interventions with motivational talk therapy have been found effective for patients with or without an initial desire to achieve cannabis abstinence. All of these psychotherapeutic interventions are effective at evidence level Ia. The administration of gabapentin had a weak effect (d = 0.26) on the quantity consumed and on abstinence (evidence level Ib). Withdrawal symptoms can be alleviated with cannabinoid-receptor antagonists (d = 0.223 and 0.481) (evidence level Ib). On the other hand, there is evidence that serotonergic antidepressants can worsen withdrawal manifestations and increase the likelihood of relapse. Conclusion: Psychotherapeutic techniques remain the foundation of treatment for cannabis dependence. No drug has yet been approved for the treatment of cannabis dependence because of the lack of scientific evidence. The rates of abstinence that are currently achieved, even with psychotherapy, are still only moderate. Further clinical studies are needed for the evaluation of combinations of various treatments that can meet the needs of individual patients.
引用
收藏
页码:653 / +
页数:9
相关论文
共 50 条
  • [1] Evidence-based treatment options for allergic diseases in otolaryngology
    Klimek, L.
    Sperl, A.
    HNO, 2013, 61 (06) : 525 - 537
  • [2] Evidence-based options for treatment-resistant adult bipolar disorder patients
    Poon, Shi Hui
    Sim, Kang
    Sum, Min Yi
    Kuswanto, Carissa Nadia
    Baldessarini, Ross J.
    BIPOLAR DISORDERS, 2012, 14 (06) : 573 - 584
  • [3] Adolescent Substance Use Disorder Treatment: an Update on Evidence-Based Strategies
    Fadus, Matthew C.
    Squeglia, Lindsay M.
    Valadez, Emilio A.
    Tomko, Rachel L.
    Bryant, Brittany E.
    Gray, Kevin M.
    CURRENT PSYCHIATRY REPORTS, 2019, 21 (10)
  • [4] Interstitial cystitis/painful bladder syndrome: epidemiology, pathophysiology and evidence-based treatment options
    Davis, N. F.
    Brady, C. M.
    Creagh, T.
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2014, 175 : 30 - 37
  • [5] Navigating Antiplatelet Treatment Options for Stroke: Evidence-Based and Pragmatic Strategies
    Moustafa, Bayan
    Testai, Fernando D.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2022, 22 (11) : 789 - 802
  • [6] Refractoriness in Bipolar Disorder: Definitions and Evidence-Based Treatment
    Fountoulakis, Konstantinos N.
    CNS NEUROSCIENCE & THERAPEUTICS, 2012, 18 (03) : 227 - 237
  • [7] An evidence-based approach in the treatment of Huntington's disease
    Mestre, T. A.
    Ferreira, J. J.
    PARKINSONISM & RELATED DISORDERS, 2012, 18 (04) : 316 - 320
  • [8] Hirsutism: An Evidence-Based Treatment Update
    Somani, Najwa
    Turvy, Diane
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2014, 15 (03) : 247 - 266
  • [9] Melasma Treatment: An Evidence-Based Review
    McKesey, Jacqueline
    Tovar-Garza, Andrea
    Pandya, Amit G.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2020, 21 (02) : 173 - 225
  • [10] Current and emerging evidence-based treatment options in chronic migraine: a narrative review
    Agostoni, Elio Clemente
    Barbanti, Piero
    Calabresi, Paolo
    Colombo, Bruno
    Cortelli, Pietro
    Frediani, Fabio
    Geppetti, Pietrangelo
    Grazzi, Licia
    Leone, Massimo
    Martelletti, Paolo
    Pini, Luigi Alberto
    Prudenzano, Maria Pia
    Sarchielli, Paola
    Tedeschi, Gioacchino
    Russo, Antonio
    JOURNAL OF HEADACHE AND PAIN, 2019, 20 (01)